| Predicate |
Object |
| contentType |
Newspaper Article |
| endingPage |
3 |
| issn |
1551-8396 |
| issueIdentifier |
3 |
| pageRange |
1-3 |
| publicationName |
The Hopkins HIV report : a bimonthly newsletter for healthcare providers |
| startingPage |
1 |
| bibliographicCitation |
Gallant JE. The optimal use of enfuvirtide. Hopkins HIV Rep. 2003 May;15(3):1–3. PMID: 12809103. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_843474d260cae6c001233727a694256d |
| date |
200305 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12809103 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1551-8396
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22217 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
The optimal use of enfuvirtide |
| discusses |
http://id.nlm.nih.gov/mesh/M0274523
http://id.nlm.nih.gov/mesh/M0024085
http://id.nlm.nih.gov/mesh/M0365995
http://id.nlm.nih.gov/mesh/M0016224 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D015700Q000008
http://id.nlm.nih.gov/mesh/D023581Q000008
http://id.nlm.nih.gov/mesh/D015658Q000188
http://id.nlm.nih.gov/mesh/D010446Q000008 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D007279
http://id.nlm.nih.gov/mesh/D014486
http://id.nlm.nih.gov/mesh/D015700Q000627
http://id.nlm.nih.gov/mesh/D016879
http://id.nlm.nih.gov/mesh/D023581Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010446Q000627
http://id.nlm.nih.gov/mesh/D000077560
http://id.nlm.nih.gov/mesh/D014481 |